弱视治疗——国内外最新指南和专家共识对比

Comparison between the latest guidelines and expert consensuses at home and abroad in amblyopia treatment

弱视是指视觉发育期由于形觉剥夺和(或)双眼异常的相互作用导致最佳矫正视力低于相应年龄视力或低于对侧眼视力2行及以上。2022年美国眼科学会更新了弱视临床指南(PPP)中的治疗建议,2021年我国中华医学会眼科学分会斜视与小儿眼科学组也发表了《中国儿童弱视防治专家共识(2021年)》。本文将2022年版PPP与2017年版《Amblyopia Preferred Practice Pattern》以及我国2021年专家共识进行对比分析,重点解读新版PPP在治疗方面的更新内容,以及国内外在治疗方式及随访评估上的差异,以期与国内眼科同道分享弱视的最新治疗进展。

Amblyopia is a condition in which the best-corrected visual acuity is less than the age-appropriate visual acuity or is two or more lines worse than the fellow eye,due to form deprivation and/or abnormal binocular interaction during visual immaturity.In 2022,the American Academy of Ophthalmology updated the treatment recommendations in the Preferred Practice Pattern(PPP).In 2021,the Chinese Association for Pediatric Ophthalmology and Strabismus published the Expert Consensus on Prevention and Treatment of Amblyopia in Children(2021).This article compares and analyzes the PPP 2022,the Amblyopia Preferred Practice Pattern 2017 and the Chinese Expert Consensus 2021,focusing on the updates of the new version of the PPP in terms of treatment,as well as the differences between China and foreign countries in treatment modalities and follow-up assessment,with a view to share with Chinese ophthalmic colleagues about the latest treatment of amblyopia.